Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NSCLC
Pharma
Keytruda catches up with Opdivo in rare lung cancer type
Merck's Keytruda has reported a trial win that could allow it to go after BMS' Opdivo and Yervoy in mesothelioma.
Angus Liu
Mar 10, 2023 10:00am
Merck doesn't expect immediate boost from Keytruda's last nod: CEO
Feb 2, 2023 11:24am
Eagle's Pemfexy catches up with Lilly's Alimta in lung cancer
Dec 19, 2022 10:25am
Eli Lilly's Retevmo gets FDA nod to treat all RET cancer types
Sep 22, 2022 11:15am
FDA accepts AZ's application for tremelimumab in liver cancer
Apr 25, 2022 9:29am
NICE grants Merck's Keytruda rare nod for 1L use in NSCLC
Jan 7, 2022 9:48am